Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy
Official title: Real-world Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2025-09-22
Completion Date
2029-05-14
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Interventions
xanomeline and trospium chloride (X/T) therapy
According to the product label
Locations (17)
Local Institution - 0009
Orange, California, United States
Lumos Clinical Research Center
San Jose, California, United States
Local Institution - 0003
Evanston, Illinois, United States
Local Institution - 0007
Baltimore, Maryland, United States
Local Institution - 0017
Bel Air, Maryland, United States
Local Institution - 0004
Catonsville, Maryland, United States
Local Institution - 0008
Belmont, Massachusetts, United States
Local Institution - 0002
Boston, Massachusetts, United States
Mayflower Clinical
South Dartmouth, Massachusetts, United States
Omaha Insomnia and Psychiatric Services
Omaha, Nebraska, United States
Hackensack Meridian Health - Carrier Clinic
Belle Mead, New Jersey, United States
Local Institution - 0015
New York, New York, United States
Local Institution - 0016
Kinston, North Carolina, United States
Local Institution - 0014
Westlake, Ohio, United States
Continuum Health Providers
Fort Mill, South Carolina, United States
Local Institution - 0012
El Paso, Texas, United States
Local Institution - 0013
Longview, Texas, United States